346 related articles for article (PubMed ID: 15514208)
21. Alterations of blood vessel development by endothelial cells overexpressing fibroblast growth factor-2.
Ribatti D; Gualandris A; Belleri M; Massardi L; Nico B; Rusnati M; Dell'Era P; Vacca A; Roncali L; Presta M
J Pathol; 1999 Dec; 189(4):590-9. PubMed ID: 10629563
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of the tyrosine phosphatase SHP-2 suppresses angiogenesis in vitro and in vivo.
Mannell H; Hellwig N; Gloe T; Plank C; Sohn HY; Groesser L; Walzog B; Pohl U; Krotz F
J Vasc Res; 2008; 45(2):153-63. PubMed ID: 17962719
[TBL] [Abstract][Full Text] [Related]
23. Paracrine and autocrine effects of fibroblast growth factor-4 in endothelial cells.
Dell'Era P; Belleri M; Stabile H; Massardi ML; Ribatti D; Presta M
Oncogene; 2001 May; 20(21):2655-63. PubMed ID: 11420677
[TBL] [Abstract][Full Text] [Related]
24. Inhibition of angiogenesis and tumor growth by SCH221153, a dual alpha(v)beta3 and alpha(v)beta5 integrin receptor antagonist.
Kumar CC; Malkowski M; Yin Z; Tanghetti E; Yaremko B; Nechuta T; Varner J; Liu M; Smith EM; Neustadt B; Presta M; Armstrong L
Cancer Res; 2001 Mar; 61(5):2232-8. PubMed ID: 11280792
[TBL] [Abstract][Full Text] [Related]
25. Nuclear localization of basic fibroblast growth factor is mediated by heparan sulfate proteoglycans through protein kinase C signaling.
Hsia E; Richardson TP; Nugent MA
J Cell Biochem; 2003 Apr; 88(6):1214-25. PubMed ID: 12647303
[TBL] [Abstract][Full Text] [Related]
26. PI-88 and novel heparan sulfate mimetics inhibit angiogenesis.
Ferro V; Dredge K; Liu L; Hammond E; Bytheway I; Li C; Johnstone K; Karoli T; Davis K; Copeman E; Gautam A
Semin Thromb Hemost; 2007 Jul; 33(5):557-68. PubMed ID: 17629854
[TBL] [Abstract][Full Text] [Related]
27. alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells.
Urbinati C; Bugatti A; Giacca M; Schlaepfer D; Presta M; Rusnati M
J Cell Sci; 2005 Sep; 118(Pt 17):3949-58. PubMed ID: 16105876
[TBL] [Abstract][Full Text] [Related]
28. A computational model of fibroblast growth factor-2 binding to endothelial cells under fluid flow.
Patel NS; Reisig KV; Clyne AM
Ann Biomed Eng; 2013 Jan; 41(1):154-71. PubMed ID: 22825797
[TBL] [Abstract][Full Text] [Related]
29. Sulfated malto-oligosaccharides bind to basic FGF, inhibit endothelial cell proliferation, and disrupt endothelial cell tube formation.
Foxall C; Wei Z; Schaefer ME; Casabonne M; Fugedi P; Peto C; Castellot JJ; Brandley BK
J Cell Physiol; 1996 Sep; 168(3):657-67. PubMed ID: 8816920
[TBL] [Abstract][Full Text] [Related]
30. Angiogenic response of endothelial cells to heparin-binding domain of fibronectin.
Viji RI; Kumar VB; Kiran MS; Sudhakaran PR
Int J Biochem Cell Biol; 2008; 40(2):215-26. PubMed ID: 17766169
[TBL] [Abstract][Full Text] [Related]
31. Long pentraxin 3/tumor necrosis factor-stimulated gene-6 interaction: a biological rheostat for fibroblast growth factor 2-mediated angiogenesis.
Leali D; Inforzato A; Ronca R; Bianchi R; Belleri M; Coltrini D; Di Salle E; Sironi M; Norata GD; Bottazzi B; Garlanda C; Day AJ; Presta M
Arterioscler Thromb Vasc Biol; 2012 Mar; 32(3):696-703. PubMed ID: 22267482
[TBL] [Abstract][Full Text] [Related]
32. Proangiogenic action of thyroid hormone is fibroblast growth factor-dependent and is initiated at the cell surface.
Davis FB; Mousa SA; O'Connor L; Mohamed S; Lin HY; Cao HJ; Davis PJ
Circ Res; 2004 Jun; 94(11):1500-6. PubMed ID: 15117822
[TBL] [Abstract][Full Text] [Related]
33. The thymidine phosphorylase inhibitor 5'-O-tritylinosine (KIN59) is an antiangiogenic multitarget fibroblast growth factor-2 antagonist.
Liekens S; Bronckaers A; Belleri M; Bugatti A; Sienaert R; Ribatti D; Nico B; Gigante A; Casanova E; Opdenakker G; Pérez-Pérez MJ; Balzarini J; Presta M
Mol Cancer Ther; 2012 Apr; 11(4):817-29. PubMed ID: 22302099
[TBL] [Abstract][Full Text] [Related]
34. Identification of sokotrasterol sulfate as a novel proangiogenic steroid.
Murphy S; Larrivée B; Pollet I; Craig KS; Williams DE; Huang XH; Abbott M; Wong F; Curtis C; Conrads TP; Veenstra T; Puri M; Hsiang Y; Roberge M; Andersen RJ; Karsan A
Circ Res; 2006 Aug; 99(3):257-65. PubMed ID: 16794189
[TBL] [Abstract][Full Text] [Related]
35. The minimal active domain of endostatin is a heparin-binding motif that mediates inhibition of tumor vascularization.
Olsson AK; Johansson I; Akerud H; Einarsson B; Christofferson R; Sasaki T; Timpl R; Claesson-Welsh L
Cancer Res; 2004 Dec; 64(24):9012-7. PubMed ID: 15604266
[TBL] [Abstract][Full Text] [Related]
36. Laminin alpha5 chain metastasis- and angiogenesis-inhibiting peptide blocks fibroblast growth factor 2 activity by binding to the heparan sulfate chains of CD44.
Hibino S; Shibuya M; Hoffman MP; Engbring JA; Hossain R; Mochizuki M; Kudoh S; Nomizu M; Kleinman HK
Cancer Res; 2005 Nov; 65(22):10494-501. PubMed ID: 16288042
[TBL] [Abstract][Full Text] [Related]
37. Antiangiogenesis and anticancer efficacy of TA138, a novel alphavbeta3 antagonist.
Mousa SA; Mohamed S; Wexler EJ; Kerr JS
Anticancer Res; 2005; 25(1A):197-206. PubMed ID: 15816539
[TBL] [Abstract][Full Text] [Related]
38. Therapeutic Potential of Anti-Angiogenic Multitarget N,O-Sulfated E. Coli K5 Polysaccharide in Diabetic Retinopathy.
Rezzola S; Dal Monte M; Belleri M; Bugatti A; Chiodelli P; Corsini M; Cammalleri M; Cancarini A; Morbidelli L; Oreste P; Bagnoli P; Semeraro F; Presta M
Diabetes; 2015 Jul; 64(7):2581-92. PubMed ID: 25695948
[TBL] [Abstract][Full Text] [Related]
39. Antiangiogenic and antiproliferative effects of substituted-1,3,4-oxadiazole derivatives is mediated by down regulation of VEGF and inhibition of translocation of HIF-1alpha in Ehrlich ascites tumor cells.
Kumar A; D'Souza SS; Nagaraj SR; Gaonkar SL; Salimath BP; Rai KM
Cancer Chemother Pharmacol; 2009 Nov; 64(6):1221-33. PubMed ID: 19370348
[TBL] [Abstract][Full Text] [Related]
40. Endothelial capillary tube formation and cell proliferation induced by tumor cells are affected by low molecular weight heparins and unfractionated heparin.
Marchetti M; Vignoli A; Russo L; Balducci D; Pagnoncelli M; Barbui T; Falanga A
Thromb Res; 2008; 121(5):637-45. PubMed ID: 17692905
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
